317
Views
2
CrossRef citations to date
0
Altmetric
Editorial

New approaches to cardiovascular diseases

&

Cardiovascular disease (CVD) is the leading cause of death in Western countries [Citation1,Citation2]. Prevention of CVD requires timely identification of people at increased risk to target effective dietary, lifestyle, or drug interventions [Citation3,Citation4]. This issue of Acta Cardiologica is dedicated to new approaches to cardiovascular diseases.

Atrial fibrillation (AF) is categorised into paroxysmal, persistent, and permanent, requiring highly individualised management approaches [Citation4–6]. Previous investigations have provided equivocal results regarding the relationship between weekend admission and early death in patients with AF. In their systematic reviews and meta-analyses, Zuin et al. reported the results of five retrospective studies involving 5164986 AF patients (mean age 69.7 years old, 47.6% males). They concluded that patients admitted during weekend for AF are characterised by an approximately 58% excess in the risk of early death () [Citation7].

Figure 1. Forest Plot for early mortality in patients with atrial fibrillation admitted during the weekend period [from reference Citation7].

Figure 1. Forest Plot for early mortality in patients with atrial fibrillation admitted during the weekend period [from reference Citation7].

Mitral valve prolapse (MVP) is the most common valvular heart disease that affects 1-3% of the general population. Most patients are asymptomatic with good long-term prognosis. Arrhythmic mitral valve prolapse, defined as MVP in the presence of frequent or complex ventricular arrhythmia, is a rare feature (<1% per year) among MVP patients [Citation8]. A typical arrhythmic MVP phenotype would be that of a young female patient with history of syncope, inferior T-wave inversions (TWI) on electrocardiogram (ECG), bileaflet prolapse, mitral annular disjunction (MAD), the Pickelhaube sign (lateral annular velocity spike of ≥16cm/s), systolic curling of the posterior wall, marked billowing excursion, mechanical dispersion and post-systolic shortening on echocardiogram, and the presence of fibrosis (late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) [Citation9]. High-risk phenotypes identified in the meta-analyses of Benjanuwattra et al. were by bileaflet prolapse, LGE, MAD, TWI, and history of syncope [Citation10].

Transvenous lead extractions (TLE) are increasingly performed in cases of malfunction or infection of cardiac implantable electronic devices, but they carry the potential for complications and suboptimal success. Examining the data of 363 TLE from 200 patients, Abdelazeem et al. showed that the most important factor that increased TLE procedural difficulty was a longer lead indwelling time, followed by passive fixation and dual-coil leads. Other contributing factors were the presence of infection, coronary sinus leads, older patients, a history of valvular heart disease and right ventricular leads [Citation11].

Measuring fractional flow reserve (FFR) with a pressure wire at the time of coronary angiography identifies coronary lesions that are responsible for significant ischaemia and identifies patients most likely to benefit from PCI [Citation12–15]. Microcatheter (MC) derived FFR system has an increased profile compared with pressure-wire derived FFR, which can increase the degree of coronary artery stenosis and lower the measured FFR value. In their study, Boutaleb et al. investigated the crossing profile characteristics of the NAVVUS® microcatheter as compared with the COMETTM pressure wire. The authors confirmed the poor crossing profile of the NAVVUS® microcatheter although FFR measures with both systems were well correlated [Citation16].

Poudineh et al. reported in a large prospective cohort the association between haematologic factors and CVD risk [Citation17]. In a total of 9,704 patients, the authors showed that among the included factors, white blood cell, and platelet distribution width had the strongest correlation with the development of CVD.

Myocardial deformation parameters have been shown to yield early detection of pathological changes in chronic heart failure [Citation18,Citation19]. Kersten et al. evaluated cardiac magnetic resonance imaging myocardial deformation changes under optimal medical therapy (OMT) in 57 CHF patients. They showed a positive reverse remodelling with improvement of left ventricular volumes and function and right ventricular global longitudinal strain at 140 days under OMT () [Citation20].

Figure 2. Example of feature tracking strain analysis in a patient with heart failure with reduced ejection fraction. Shown is a colour-coded visualisation of the right ventricular (from reference [Citation20].

Figure 2. Example of feature tracking strain analysis in a patient with heart failure with reduced ejection fraction. Shown is a colour-coded visualisation of the right ventricular (from reference [Citation20].

Mobile health systems provide a multifaceted strategy for risk factor management by maintaining vital touch with patients, teaching them about healthy lifestyle choices, and enabling precise lifestyle control. In their study, Hayıroğlu et al. showed that the smart device and mobile application technologies increased VO2 measurements in individuals with high CV risk compared to conventional treatment alone [Citation21]. In the context of coronary artery disease (CAD), proton pump inhibitors (PPIs) are commonly prescribed along with antiplatelet medications. However, the potential interaction between these two classes of medications has been subject to much debate. Teperikidis et al. conducted a comprehensive search of PubMed to identify relevant systematic reviews and meta-analyses examining the association between PPI use and major adverse cardiovascular events. A total 46 randomised controlled trials and 33 observational studies were identified. The findings of this umbrella review suggested that a causal relationship between PPI use and an increased risk of adverse CV events cannot be ruled out [Citation22].

Bacterial infective endocarditis (IE) is a life-threatening condition for which a prompt treatment is mandatory to avoid heart valve destruction and septic embolism. These dreadful complications continue to be the leading causes of mortality and morbidity from IE, despite significant progresses in diagnostic methods and algorithms [Citation23–25]. Vandoren et al. published a nice image focus reporting the case of a patient with IE who eventually died from right coronary artery septic embolisation. Interestingly, the diagnosis was made on catheter coronary angiography, which is the most common diagnostic procedure for coronary embolizations as it is indicated preoperatively in IE when a surgical valve replacement is contemplated [Citation26].

In this issue of Acta Cardiologica, several focus images and cases highlighting interesting clinical conditions have also been reported [Citation27–29].

Disclosure statement

No potential conflict of interest was reported by the author(s).

References

  • Lancellotti P, Cosyns B. Highlights of acta cardiologica. Acta Cardiol. 2022;77(6):469–470. doi:10.1080/00015385.2022.2143092.
  • Lancellotti P, Petitjean H, Nchimi A, et al. Special issue on ischemic heart disease. Acta Cardiol. 2023;78(1):1–4. doi:10.1080/00015385.2023.2170563.
  • Lancellotti P. Focus on cardiometabolic risk factors. Acta Cardiol. 2023;78(5):515–518. doi:10.1080/00015385.2023.2231702.
  • Lancellotti P, Piette C. Special issue on atrial fibrillation. Acta Cardiol. 2023;78(3):269–273. doi:10.1080/00015385.2023.2205277.
  • Claeys MJ, Bondue A, Lancellotti P, et al. Summary of 2020 ESC guidelines on non-STE ACS, adult congenital heart disease, sports cardiology and atrial fibrillation. Acta Cardiol. 2022;77(10):864–872. doi:10.1080/00015385.2021.2003062.
  • Mei DA, Romiti GF, Boriani G. Prepare our healthcare systems to manage complexity: the case of atrial fibrillation. Acta Cardiol. 2023;11:1–3. doi:10.1080/00015385.2023.2232691.
  • Zuin M, Rigatelli G, Bilato C. Weekend atrial fibrillation hospitalizations are associated with higher short-term mortality. Acta Cardiol. 2023;20:1–6. doi:10.1080/00015385.2023.2223007.
  • Lancellotti P, Garbi M. Malignant mitral valve prolapse: substrates to ventricular remodeling and arrhythmias. Circ Cardiovasc Imaging. 2016;9(8):e005248. doi:10.1161/CIRCIMAGING.116.005248.
  • Kubala M, de Chillou C, Bohbot Y, et al. Arrhythmias in patients with valvular heart disease: gaps in knowledge and the way forward. Front Cardiovasc Med. 2022;9:792559. eCollection 2022. doi:10.3389/fcvm.2022.792559.
  • Benjanuwattra J, Kewcharoen J, Phinyo P, et al. High-risk phenotypes of arrhythmic mitral valve prolapse: a systematic review and meta-analysis. Acta Cardiol. 2023;26:1–8. doi:10.1080/00015385.2023.2227487.
  • Abdelazeem A, Ahmed A, Curnis A, et al. Transvenous lead extraction, factors affecting procedural difficulty. Acta Cardiol. 2023;15:1–8. doi:10.1080/00015385.2023.2222986.
  • Lancellotti P, Go YY, Nchimi A. Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg? Eur Heart J. 2022;43(33):3129–3131. doi:10.1093/eurheartj/ehac287.
  • Kasinadhuni G, Batta A, Gawalkar AA, et al. Validity and correlation of quantitative flow ratio with fractional flow reserve for assessment of intermediate coronary lesions. Acta Cardiol. 2023;78(1):91–98. doi:10.1080/00015385.2022.2059857.
  • Desmet W. Will quantitative flow ratio replace fractional flow reserve in the cathlab? Commentary to "validity and correlation of quantitative flow ratio with fractional flow reserve for assessment of intermediate coronary lesions. Acta Cardiol. 2022;77(8):673–673. doi:10.1080/00015385.2022.2084820.
  • Jong CB, Liao MT, Lu TS, et al. Efficacy and safety of High-Dose intracoronary adenosine injection in fractional flow reserve assessment. Acta Cardiol Sin. 2022;38:553–563.
  • Boutaleb AM, Scalia A, Ghafari C, et al. Microcatheter- versus wire-based measurement of the fractional flow reserve. Acta Cardiol. 2023;15:1–9. doi:10.1080/00015385.2023.2246009.
  • Poudineh M, Mansoori A, Sadooghi Rad E, et al. Platelet distribution widths and white blood cell are associated with cardiovascular diseases: data mining approaches. Acta Cardiol. 2023;11:1–12. doi:10.1080/00015385.2023.2246199.
  • Lancellotti P, Postolache A, Dulgheru R. Highlights of imaging heart structure and function. Acta Cardiol. 2023;78(4):383–386. doi:10.1080/00015385.2023.2206690.
  • Lancellotti P, Ribeiro Coelho S, Nguyen Trung ML, et al. Special issue on heart failure. Acta Cardiol. 2023;78(2):165–167. doi:10.1080/00015385.2023.2182985.
  • Kersten J, Hackenbroch C, Gann P, et al. Myocardial deformation parameters assessed by CMR feature tracking in chronic heart failure: the influence of an optimal medical therapy on myocardial remodeling. Acta Cardiol. 2023;22:1–6. doi:10.1080/00015385.2023.2246202.
  • Hayıroğlu Mİ, Çınar T, Cilli Hayıroğlu S, et al. The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a Sub-study of the LIGHT randomized clinical trial. Acta Cardiol. 2023;15:1–6. doi:10.1080/00015385.2023.2223005.
  • Teperikidis E, Boulmpou A, Potoupni V, et al. Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella review. Acta Cardiol. 2023;11:1–9. doi:10.1080/00015385.2023.2231299.
  • Allaeys T, Jongman L, Paelinck BP, et al. Endocarditis and an unexpected entry port. Acta Cardiol. 2022;77(6):551–552. doi:10.1080/00015385.2021.1902107.
  • Oliveira I, Bragança B, Neto A, et al. Infective endocarditis nightmare: a bold solution for a devastating scenario. Acta Cardiol. 2022;77(10):970–971. doi:10.1080/00015385.2022.2030556.
  • Nchimi A, Oury C, Lancellotti P. From charybdis to scylla when acute coronary syndrome complicates endocarditis. Acta Cardiol. 2023;11;1:1. doi:10.1080/00015385.2023.2192154.
  • Vandoren V, Dujardin K, Timmermans PJ. Acute coronary syndrome related to prosthetic valve endocarditis. Acta Cardiol. 2022;77(10):978–979. doi:10.1080/00015385.2022.2100609.
  • Van Oeteren I, Achten R, Ghekiere O, et al. Hidden in plain sight: complex tachycardias in a young thalassemia patient. Acta Cardiol. 2023;15:1–4. doi:10.1080/00015385.2023.2223014.
  • Abramikas Z, Zakarkaite D, Janusauskas V, et al. Successful surgical treatment of cardiac implantable electronic device – related infection. Acta Cardiol. 2023;14(1):1. doi:10.1080/00015385.2023.2229597.
  • Sazhinyan A, Nguyen T. Elevated D-dimers in a patient with atrial flutter. Acta Cardiol. 2023;11(1):1. doi:10.1080/00015385.2023.2252614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.